STAAR Surgical Company STAA
25.17 USD +0.23 (+0.92%)
At closeNov 3, 2026, 4:01 PM EST
25.17 0.00 0.00%
After hours · Nov 3, 4:01 PM ET
24.56 Day range 25.28
15.59 52-week range 35.87
- YTD
- +9.01%
- 1 year
- -0.36%
Analyst view
Consensus: buy
Buy
Price target (mean) 27.67 +9.9% upside
Now 25.17
- Target (low)
- 19.00
- Target (mean)
- 27.67
- Target (high)
- 37.00
Ratings (0m) 11 4 buy · 6 hold · 1 sell
- Strong buy0
- Buy4
- Hold6
- Sell1
- Strong sell0
Recommendation trend
- This month 11
- 1 month ago 12
- 2 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.16857 | 0.06 – 0.24 | 0.47136 | -64.2% | 78.73M | -16.9% | 7 |
| Next quarter | 0.09429 | 0.02 – 0.16 | 0.00802 | +1075.7% | 68.40M | +18.3% | 7 |
| Current year | 0.84 | 0.40 – 1.07 | -0.16646 | +604.6% | 334.30M | +39.6% | 7 |
| Next year | 1.11 | 0.77 – 1.42 | 0.84 | +32.3% | 360.56M | +7.9% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 29, 2026 | Stifel | Upgrade | Hold | Buy |
| Sep 22, 2026 | Jefferies | Maintained | Buy | Buy |
| Aug 17, 2026 | Stifel | Maintained | Hold | Hold |
| Aug 13, 2026 | UBS | Maintained | Sell | Sell |
| Aug 13, 2026 | Jefferies | Maintained | Buy | Buy |
| Aug 13, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Aug 4, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| Jul 28, 2026 | UBS | Initiated | — | Sell |
| Jul 22, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| Jul 16, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| May 29, 2026 | Wedbush | Reiterated | Outperform | Outperform |
| May 15, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| May 14, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| May 14, 2026 | Piper Sandler | Maintained | Neutral | Neutral |
| May 14, 2026 | Stifel | Maintained | Hold | Hold |
| May 14, 2026 | Wedbush | Upgrade | Neutral | Outperform |
| May 14, 2026 | Mizuho | Maintained | Neutral | Neutral |
| Apr 9, 2026 | Wedbush | Maintained | Neutral | Neutral |
| Apr 9, 2026 | Canaccord Genuity | Upgrade | Hold | Buy |
| Mar 5, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Mar 4, 2026 | Stifel | Maintained | Hold | Hold |
| Feb 9, 2026 | Stifel | Maintained | Hold | Hold |
| Feb 3, 2026 | Wedbush | Initiated | — | Neutral |
| Jan 28, 2026 | Jefferies | Maintained | Buy | Buy |
| Jan 16, 2026 | Canaccord Genuity | Maintained | Hold | Hold |
| Dec 10, 2025 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Dec 10, 2025 | Canaccord Genuity | Maintained | Hold | Hold |
| Aug 7, 2025 | Stifel | Downgrade | Buy | Hold |
| Aug 6, 2025 | Canaccord Genuity | Maintained | Hold | Hold |
| Aug 5, 2025 | Sidoti & Co. | Downgrade | Buy | Neutral |